<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://mex.alphagenics.co/blog/mex-cofepris-tirzepatida-sin-registro-aviso-riesgo-2026/</loc><news:news><news:publication><news:name>Alphagenics México</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-06</news:publication_date><news:title>Tirzepatida sin registro en México: aviso de riesgo de Cofepris</news:title></news:news></url><url><loc>https://mex.alphagenics.co/blog/mex-lenacapavir-generico-40-dolares-cofepris-fda/</loc><news:news><news:publication><news:name>Alphagenics México</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-07</news:publication_date><news:title>Lenacapavir genérico a 40 dólares: México, fuera de las licencias</news:title></news:news></url><url><loc>https://mex.alphagenics.co/blog/mex-sedena-740-millones-medicamentos-soluglob-ikon-cofepris/</loc><news:news><news:publication><news:name>Alphagenics México</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-06</news:publication_date><news:title>Sedena adjudica 740 millones en medicamentos a empresa sancionada</news:title></news:news></url></urlset>
